AzTrials
AzTrials

Traumatic Brain InjuryNCT01883830

Xbox in the Rehabilitation of Chronic Traumatic Brain Injury

A study testing gaming therapy (Xbox) and Dynamic balance platform (Biodex) in people with Traumatic Brain Injury and Balance Disorders, run by University Hospital of Ferrara at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Traumatic brain injury is an extremely common disease, it counts 50.000 deaths and 235.000 hospitalizations every year. Functional consequences of an acquired brain injury have a considerable impact on quality of lives of patients and care-givers with direct effects on balance, mobility and on psycho-social functions. Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
gaming therapy (Xbox) and Dynamic balance platform (Biodex)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteItaly
Study dates
Apr 2013to May 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Chronic traumatic brain injury (>12 months)
  • Age>18, <70 years old
  • Presence of a moderate balance deficit identified by UBS with a score>15 and < 60 or presence of a selective attention and shifting attention deficit identified by the TEA computerized battery (Tau<37).

Who cannot join

  • Neurologic diseases associated with possible involvement of motor functions
  • Medical conditions that could interfere with the safe conclusion of the study protocol
  • Severe cognitive-behavioural diseases (LCF<6),
  • severe psychiatric diseases
  • Use of walking aids

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Ferrara University Hospital

    Ferrara, Italy

Other trials in Italy

About this study

Official title: "Feasibility and Efficacy of Virtual Reality With Xbox Kinect in the Rehabilitation of Cronic Traumatic Brain Injuries: a Randomized Controlled Trial".

Traumatic brain injury is an extremely common disease, it counts 50.000 deaths and 235.000 hospitalizations every year. Functional consequences of an acquired brain injury have a considerable impact on quality of lives of patients and care-givers with direct effects on balance, mobility and on psycho-social functions. Attention deficits are one of the most frequent and disabling consequences of severe brain injury. Within the wide spectrum of attentive problems, patients with traumatic brain injury frequently have shown difficulties in divided attention. Patients, care-givers and professionals frequently refer difficulties also in selective attention and vigilance as consequence of the trauma. It has been shown how these difficulties are tightly related with the missed return to work after two years from the injury.

The hypothesis of this study is to investigate the feasibility of a rehabilitative protocol on gaming using the console Xbox and its efficacy in improving balance, mobility, risk of falling, attentive functions (selective and divided attention) in subjects which have had a traumatic brain injury at least 12 months before.

Read the detailed description

Inclusion Criteria:

Chronic traumatic brain injury (>12 months) Age>18, <70 years old Presence of a moderate balance deficit identified by CB\&M with a score < 65 or presence of a selective attention and shifting attention deficit identified by the TEA computerized battery (Tau<37).

Being tested
gaming therapy (Xbox), Dynamic balance platform (Biodex)
Keywords
traumatic brain injury (TBI), balance disorders, attention deficits, x-box, gaming, virtual reality
Medical subject headings
Brain Injuries, Traumatic, Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gaming therapy (Xbox)Device

  • Dynamic balance platform (Biodex)Device

Study groups in NCT01883830
Study groupRoleWhat they receive
gaming therapy (Xbox)ExperimentalSubjects belonging to the first group will receive a gaming therapy protocol using the Xbox console. They will receive 24 sessions of treatment within 8 weeks (3 sessions per week). Patients will be required to concentrate in games whose major purposes are increasing balance, selective attention and attention shifting. During sessions the patient will be carefully controlled by a researcher who will prevent the risk of falling and impulsiveness reactions.
Receives: Device: gaming therapy (Xbox)
Dynamic balance platform trainingActive comparatorControl group will receive the same amount of therapy (24 sessions) using a dynamic balance platform (Biodex).
Receives: Device: Dynamic balance platform (Biodex)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in balance with Community Balance & Mobility Scale (CB&M)

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

Secondary outcomes (5)
  1. Timed Up and Go (TUG)

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

  2. Unified Balance Scale (UBS)

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

  3. Participation Objective, Participation Subjective Scale(POPS)

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

  4. postural sway

    Center of pressure (COP) trajectories

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

  5. Attentive functions evaluation Attentive functions evaluation

    TEA computerized battery

    Measured: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionMay 2016
  4. Study completionMay 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01883830
Sponsor's protocol ID
Kinect_study
Other IDs
Kinect
Status last verified
Feb 2017
First submitted
5 Apr 2013
Last updated
3 Feb 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Straudi S, Severini G, Sabbagh Charabati A, Pavarelli C, Gamberini G, Scotti A, Basaglia N. The effects of video game therapy on balance and attention in chronic ambulatory traumatic brain injury: an exploratory study. BMC Neurol. 2017 May 10;17(1):86. doi: 10.1186/s12883-017-0871-9.

    PubMed 28490322

Questions about this trial

What is this clinical trial studying?

A study testing gaming therapy (Xbox) and Dynamic balance platform (Biodex) in people with Traumatic Brain Injury and Balance Disorders, run by University Hospital of Ferrara at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in balance with Community Balance & Mobility Scale (CB&M) (time frame: 1)A week prior to treatment beginning 2) the week after treatment 3)three months follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01883830, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in